A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
JAMA Study Uncovers Moderate Caffeine Intake’s Link to Reduced Dementia Risk, Highlighting Adenosine Pathway for Drug Development
A comprehensive prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has revealed a significant…
Read More
